中文名 |
羟甲烯龙 |
---|---|
英文名 |
oxymetholone |
中文别名 |
枸橼酸托法替尼 | 17β-羟基-2-羟亚甲基-17α-甲基-5α-雄甾(烷)-3-酮 | 2-羟亚甲基-17α-甲基-5α-雄甾(烷)-17β-醇-3-酮 | 康复龙 |
英文别名 |
更多 |
密度 | 1.2±0.1 g/cm3 |
---|---|
沸点 | 465.9±45.0 °C at 760 mmHg |
熔点 | 172-180°C |
分子式 | C21H32O3 |
分子量 | 332.477 |
闪点 | 249.7±25.2 °C |
精确质量 | 332.235138 |
PSA | 57.53000 |
LogP | 4.22 |
外观性状 | 白色结晶粉末 |
蒸汽压 | 0.0±2.6 mmHg at 25°C |
折射率 | 1.590 |
分子结构 |
1、 摩尔折射率:95.89 2、 摩尔体积(m3/mol):284.2 3、 等张比容(90.2K):757.0 4、 表面张力(dyne/cm):50.3 5、 极化率(10 -24cm 3):38.01 |
更多 |
一、物性数据 性状:白色结晶性粉末,无嗅 密度(g/mL,25/4℃):不可用 相对蒸汽密度(g/mL,空气=1):不可用 熔点(?C):173-176 沸点(?C,常压):不可用 沸点(?C,5.2kPa):不可用 折射率:不可用 闪点(?C):不可用 比旋光度(?):不可用 自燃点或引燃温度(?C):不可用 蒸气压(kPa,25?C):不可用 饱和蒸气压(kPa,60?C):不可用 燃烧热(KJ/mol):不可用 临界温度(?C):不可用 临界压力(KPa):不可用 油水(辛醇/水)分配系数的对数值:不可用 爆炸上限(%,V/V):不可用 爆炸下限(%,V/V):不可用 溶解性:不溶于水,易溶于氯仿,溶于二氧六环、植物油,略溶于乙醇、乙醚 |
康复龙毒性英文版
|
符号 |
GHS08 |
---|---|
信号词 |
Warning |
危害声明 |
H351-H361 |
警示性声明 |
P281 |
个人防护装备 |
Eyeshields;full-face particle respirator type N100 (US);Gloves;respirator cartridge type N100 (US);type P1 (EN143) respirator filter;type P3 (EN 143) respirator cartridges |
危害码 (欧洲) |
T: Toxic; |
风险声明 (欧洲) |
R40 |
安全声明 (欧洲) |
S53-S22-S26-S36/37/39 |
危险品运输编码 | NONH for all modes of transport |
WGK德国 | 3 |
RTECS号 | BV8060000 |
海关编码 | 2937290023 |
可用番麻皂素或剑麻皂素经乙酰化、还原、开环、氧化、水解、消除、肟化、重排、水解、加成、氧化、水解、缩合等多步反应制得该品。
海关编码 | 2937290023 |
---|
Detection of urinary metabolites common to structurally related 17alpha-alkyl anabolic steroids in horses and application to doping tests in racehorses: methandienone, methandriol, and oxymetholone. J. Anal. Toxicol. 32(5) , 387-91, (2008)
Methandienone, methandriol, and oxymetholone, which are anabolic steroids possessing 17alpha-methyl and 17beta-hydroxy groups, were developed as oral formulations for therapeutic purposes. However, th…
|
|
Hepatocellular adenomas associated with anabolic androgenic steroid abuse in bodybuilders: a report of two cases and a review of the literature. Br. J. Sports Med. 39(5) , e27, (2005)
Anabolic androgenic steroids (AAS) are used illicitly at high doses by bodybuilders. The misuse of these drugs is associated with serious adverse effects to the liver, including cellular adenomas and …
|
|
Characterization of spontaneous and chemically induced cardiac lesions in rodent model systems: the national toxicology program experience. Cardiovasc. Toxicol. 5(2) , 227-44, (2005)
Induction of heart disease can be related to exposure to a number of agents, including environmental chemicals. Studies with laboratory rodents are commonly used to identify cardiotoxic agents and to …
|
|
(2Z,5S,8R,9S,10S,13S,14S,17S)-17-Hydroxy-2-(hydroxymethylene)-10,13,17-trimethylhexadecahydro-3H-cyclopenta[a]phenanthren-3-one |
(2Z,5α,17β)-17-hydroxy-2-(hydroxymethylidene)-17-methylandrostan-3-one |
(2Z,5S,8R,9S,10S,13S,14S,17S)-17-hydroxy-2-(hydroxyméthylidène)-10,13,17-triméthylhexadécahydro-3H-cyclopenta[a]phénanthrén-3-one |
MFCD00869395 |
Stanozolol impurity B |
Androstan-3-one, 17-hydroxy-2-(hydroxymethylene)-17-methyl-, (5α,17β)- |
(2Z,5S,8R,9S,10S,13S,14S,17S)-17-hydroxy-2-(hydroxymethylidene)-10,13,17-trimethylhexadecahydro-3H-cyclopenta[a]phenanthren-3-one |
(2Z,5α,17β)-17-Hydroxy-2-(hydroxymethylene)-17-methylandrostan-3-one |
2-Hydroxymethylene-17a-methyl-17b-hydroxy-5a-androstan-3-one |
Oxymetholone |
4,5a-Dihydro-2-hydroxymethylene-17a-methyltestosterone |
Raboral |
EINECS 207-098-6 |
Oximetholone |
2-Hydroxymethylene-17a-methylandrostan-17b-ol-3-one |
(2Z,5α,17β)-17-Hydroxy-2-(hydroxymethyliden)-17-methylandrostan-3-on |
Adroyd |
Anadroyd |
Anadrol |
Roboral |
Adroidin |
Androstan-3-one, 17-hydroxy-2-(hydroxymethylene)-17-methyl-, (2Z,5α,17β)- |
Becorel |
(5a,17b)-17-Hydroxy-2-(hydroxymethylene)-17-methylandrostan-3-one |
(2Z,5S,8R,9S,10S,13S,14S,17S)-17-Hydroxy-2-(hydroxymethyliden)-10,13,17-trimethylhexadecahydro-3H-cyclopenta[a]phenanthren-3-on |